story of the week
2-Year Effects of Semaglutide in Adults With Overweight or Obesity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Nat. Med. 2022 Oct 01;28(10)2083-2091, WT Garvey, RL Batterham, M Bhatta, S Buscemi, LN Christensen, JP Frias, E Jódar, K Kandler, G Rigas, TA Wadden, S WhartonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.